| Patient | Jackie Robinson |
|---|---|
| Date of birth | 1919-01-31 |
| Identifiers | MRN HR-ML037-SYN-TD; SSN (made up) 000-37-2286 |
| Document date | 1971-07-27 |
| Author | Marcus Delacroix-Hale, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Blurred vision in both eyes for two months and new floaters in the right eye for four days in a 52-year-old man with type 2 diabetes for about fifteen years and an A1c of 10.4%. Snellen acuity 20/200 right and 20/80 left; the undilated view of the right fundus is poor. Please examine for proliferative retinopathy, vitreous hemorrhage, retinal detachment and macular edema, and treat as needed. [S]
Urgency: Within 48 hours, by phone arrangement today; same-day attendance if a curtain over the vision or flashes appear. [S]
Questions for the consultant:
Mr. Robinson has had type 2 diabetes for about fifteen years, treated with metformin 1,000 mg twice daily and insulin glargine 30 units at bedtime; A1c today 10.4%, random glucose 248 mg/dL. He has hypertension (152/92 today on lisinopril 20 mg), albuminuria (urine albumin-to-creatinine ratio 86 mg/g, eGFR 79), peripheral artery disease with claudication at one block, loss of protective sensation in both feet, and two mild strokes a year ago without lasting weakness; he takes aspirin 81 mg, and atorvastatin was increased today to 80 mg (LDL 142 mg/dL). He reports chest tightness on stairs; a cardiology evaluation with a stress test is being arranged. He has not had a dilated eye examination for more than two years. His eldest son died six weeks ago, and he is grieving. He cannot read print or drive safely now and is afraid of losing his sight. He asks whether he must stop aspirin [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
6 later historical claims are omitted because they describe events after the index age. See the teaching note.
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Metformin 1,000 mg oral tablet, one tablet twice daily with meals | One tablet twice daily with meals | Oral route | 1970-03-03 | active | S |
| Insulin glargine 100 units/mL pen, 30 units at bedtime, adjusted by the written plan: 2 units each week while fasting glucose is above 160 mg/dL, and 4 units less for any reading below 70 | At bedtime, by the gradual titration plan | Subcutaneous route | 1970-03-03 | active | S |
| Lisinopril 20 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1970-03-03 to 1971-07-29 | completed | S |
| Atorvastatin 80 mg oral tablet, one tablet daily (increased from 40 mg at intake) | One tablet daily | Oral route | 1971-07-27 | active | S |
| Aspirin 81 mg delayed-release oral tablet, one tablet daily | One tablet daily | Oral route | 1970-03-03 | active | S |
| Glucagon 3 mg nasal powder, one spray into the nose for severe low blood sugar; may repeat once after 15 minutes | As needed for severe low blood sugar | Nasal route | 1971-07-27 | active | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Blurred vision in both eyes, worse over two months, with new floaters in the right eye for four days; acuity by Snellen chart 20/200 right and 20/80 left; undilated view poor on the right; urgent retina examination arranged | active | confirmed | H53.8 | S — Synthetic presenting finding, superseded by the retinal diagnosis two days later. |
| Tightness in the chest on climbing stairs for two months, easing with rest; ECG without acute change; cardiology evaluation with a stress test arranged | active | confirmed | R07.89 | S — Synthetic presenting finding, superseded by the coronary diagnosis after the stress test. |
| Type 2 diabetes for about fifteen years, on metformin and basal insulin, with hyperglycemia (A1c 10.4%) | active | confirmed | E11.65 | S — Synthetic modern episode linked to his documented diabetes. |
| Hypertension with chronic kidney disease, above goal on lisinopril 20 mg (152/92 mmHg) | active | confirmed | I12.9 | S — Synthetic modern episode linked to his documented high blood pressure. |
| Diabetic kidney disease with albuminuria (urine albumin-to-creatinine ratio 86 mg/g, also raised last year) and eGFR 79 | active | confirmed | E11.22 | S — Synthetic kidney findings. |
| Chronic kidney disease G2 A2 | active | confirmed | N18.2 | S — Synthetic kidney finding. |
| Peripheral artery disease of both legs with calf pain after about one block of walking; faint foot pulses | active | confirmed | E11.51 | S — Synthetic modern episode linked to the documented artery damage in his legs. |
| Diabetic peripheral neuropathy: loss of protective sensation in both feet on monofilament testing | active | confirmed | E11.42 | S — Synthetic modern episode linked to the documented nerve damage in his legs. |
| History of two mild strokes a year ago, without lasting weakness | active | confirmed | Z86.73 | S — Synthetic modern coding of the documented strokes. |
| Hyperlipidemia: LDL 142 mg/dL on atorvastatin 40 mg, far above the goal below 55 mg/dL | active | confirmed | E78.5 | S — Synthetic laboratory finding. |
| Bereavement: his eldest son died in a car crash six weeks ago | active | confirmed | Z63.4 | S — Synthetic modern coding of a documented loss; grief is treated as grief, not as a disorder. |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| about 1957 | Diabetes diagnosed at about 37, around his retirement from baseball | D (CLM-0005) |
| by 1969 | Nerve and artery damage in both legs | D (CLM-0006) |
| 1970 | Two mild strokes | D (CLM-0007) |
| Relative | Condition | Age at death | Evidence |
|---|---|---|---|
| brother | Two of his brothers had diabetes | D (CLM-0005) | |
| natural son | His eldest son died in an automobile accident at 24 | 24 | D (CLM-0011) |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1971-07-27 | Body height | 180 | cm | S |
| 1971-07-27 | Body weight | 104 | kg | S |
| 1971-07-27 | Body mass index (BMI) [Ratio] | 32.1 | kg/m2 | S |
| 1971-07-27 | Systolic blood pressure | 152 | mm[Hg] | S |
| 1971-07-27 | Diastolic blood pressure | 92 | mm[Hg] | S |
| 1971-07-27 | Heart rate | 84 | /min | S |
| 1971-07-27 | Respiratory rate | 16 | /min | S |
| 1971-07-27 | Body temperature | 36.7 | Cel | S |
| 1971-07-27 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1971-07-27 | Hemoglobin A1c/Hemoglobin.total in Blood | 10.4 | % | Below 5.7% is normal; his first goal below 8%, then below 7%, lowered gradually | High | S |
| 1971-07-27 | Glucose [Mass/volume] in Serum or Plasma | 248 | mg/dL | 70-139 mg/dL | High | S |
| 1971-07-27 | Sodium [Moles/volume] in Serum or Plasma | 137 | mmol/L | 135-145 mmol/L | Normal | S |
| 1971-07-27 | Potassium [Moles/volume] in Serum or Plasma | 4.6 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1971-07-27 | Creatinine [Mass/volume] in Serum or Plasma | 1.12 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 1971-07-27 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1966)/1.73 sq M | 79 | mL/min/{1.73_m2} | 90 or higher is normal; 60 to 89 is mildly decreased (G2) | Low | S |
| 1971-07-27 | Albumin/Creatinine [Mass Ratio] in Urine | 86 | mg/g | Below 30 mg/g normal (A1); 30 to 300 moderately increased (A2) | High | S |
| 1971-07-27 | Cholesterol [Mass/volume] in Serum or Plasma | 226 | mg/dL | <=199 mg/dL | High | S |
| 1971-07-27 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 142 | mg/dL | Goal below 55 mg/dL with atherosclerotic disease | High | S |
| 1971-07-27 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 38 | mg/dL | >=40 mg/dL | Low | S |
| 1971-07-27 | Triglyceride [Mass/volume] in Serum or Plasma | 230 | mg/dL | <=149 mg/dL | High | S |
| 1971-07-27 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 28 | U/L | 7-55 U/L | Normal | S |
| 1971-07-27 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 24 | U/L | 8-48 U/L | Normal | S |
| 1971-07-27 | Hemoglobin [Mass/volume] in Blood | 13.9 | g/dL | 13.5-17.5 g/dL | Normal | S |
| 1971-07-27 | Platelets [#/volume] in Blood by Automated count | 250 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 1971-07-27 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma | 380 | pg/mL | 232-1245 pg/mL | Normal | S |
| 1971-07-27 | Thyrotropin [Units/volume] in Serum or Plasma | 1.8 | m[IU]/L | 0.4-4.5 mIU/L | Normal | S |
| 1971-07-27 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 9 | {score} | S |